Anti-Telomerase reverse transcriptase antibody - C-terminal (ab183105)

Publishing research using ab183105? Please let us know so that we can cite the reference in this datasheet.

ab183105 has been referenced in 6 publications.

  • Yang H  et al. Concomitant underexpression of TGFBR2 and overexpression of hTERT are associated with poor prognosis in cervical cancer. Sci Rep 7:41670 (2017). WB, IHC-P ; Human . PubMed: 28195144
  • Zou MX  et al. Upregulated human telomerase reverse transcriptase (hTERT) expression is associated with spinal chordoma growth, invasion and poor prognosis. Am J Transl Res 8:516-29 (2016). PubMed: 27158344
  • Suryo Rahmanto Y  et al. Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells. J Biol Chem 291:9690-9 (2016). PubMed: 26953344
  • Patel PL  et al. Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence. Proc Natl Acad Sci U S A 113:E5024-33 (2016). ICC/IF ; Human . PubMed: 27503890
  • Liu Q  et al. TERT alleviates irradiation-induced late rectal injury by reducing hypoxia-induced ROS levels through the activation of NF-?B and autophagy. Int J Mol Med 38:785-93 (2016). IHC-P ; Mouse . PubMed: 27431814
  • Naidoo K  et al. Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity. PLoS One 10:e0141618 (2015). PubMed: 26545108

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up